Fluorescence-guided surgery has become one of the most significant revolutions in modern surgical medicine. Through the selective fluorescent staining of certain tissues, it adds a new level of precision during surgical procedures. Thanks to dyes such as indocyanine green (ICG) and high-precision optical systems, this technique enables real-time visualization of anatomical structures, perfusion and tumor tissue in the operating room, offering a new dimension of safety and effectiveness during surgery.
Fluorescence helps surgeons more accurately delineate tumor margins, assess tissue viability and detect lymph nodes or microlesions that are invisible to the human eye. The result is more precise, less invasive surgery with improved functional and oncological outcomes for patients.
ISFGS 2025: Madrid to Host the International Meeting on Fluorescence-Guided Surgery
On November 21, 2025, Madrid will host the European Chapter Meeting 2025 of the International Society for Fluorescence Guided Surgery (ISFGS), the leading international scientific society in this field.
The event, which will take place at CEU San Pablo University, will bring together surgeons, researchers and medical innovation experts from around the world.
The sessions will address the latest advances in the use of ICG, new targeted dyes and new optical systems across multiple specialties, including digestive oncology, hepatobiliary surgery, gynecologic surgery, vascular surgery, plastic surgery, urology, pediatric surgery, minimally invasive surgery and even veterinary surgery.
Application of ICG in Peritoneal Oncology: Dr. Delia Cortés Guiral’s Presentation in Madrid
Dr. Delia Cortés Guiral, director of IVOQA and specialist in peritoneal and digestive oncologic surgery, will play a leading role as Meeting Convener and speaker.
In addition to chairing the scientific organizing committee, she will deliver the lecture titled “ICG in Peritoneal Surface Malignancy (PSM).”
During her talk, Dr. Cortés will present the innovative protocols developed at IVOQA for applying fluorescence during surgery for peritoneal carcinomatosis, both in cytoreductive surgery and HIPEC, as well as during PIPAC treatments.
Thanks to this methodology, it is possible to detect lesions that might go unnoticed by sight or touch, optimize resection margins and reduce the risk of tumor recurrence, especially in patients with peritoneal carcinomatosis or localized metastatic disease. The revolution brought by this technique in peritoneal surgery opens the door to achieving more precise procedures, since one of the main challenges in this type of surgery is the presence of occult disease in apparently healthy peritoneum.
Her participation strengthens the leadership of IVOQA and Viamed Salud on the international scene and reinforces Spain’s presence in the most prestigious forums on fluorescence-guided surgery.
Fluorescence and Oncologic Surgery: A New Era of Precision
Intraoperative fluorescence is redefining oncologic surgery by enabling real-time decision-making based on dynamic imaging.
Indocyanine green (ICG), which binds to plasma proteins and emits a signal under infrared light, acts as a biocompatible and safe marker to visualize perfusion and tumor spread.
This technology marks the beginning of a new era of personalized surgery, where planning, execution and evaluation are adapted to each patient’s biological response.
IVOQA is a center that has incorporated this technique into cancer surgeries, both in open, laparoscopic and robotic procedures, achieving relevant clinical results in peritonectomies, HIPEC, PIPAC and advanced colorectal surgery. The center continues to advance its commitment to research for the development of fluorescence protocols tailored to each peritoneal pathology.
Commitment to Research, Teaching and Innovation
The celebration in Madrid of the ISFGS European Chapter 2025 and the appointment of Dr. Delia Cortés Guiral as organizer and president of the congress represent recognition of her scientific career and the commitment of IVOQA and Viamed Salud to medical and technological excellence.
Through active participation in international forums, publication of clinical studies and collaboration with scientific societies, IVOQA consolidates its leadership in the development of fluorescence-guided surgical techniques and its mission to offer more precise, safer and more humane oncologic surgery.
IVOQA and Viamed Salud, Leaders in Advanced Oncologic Surgery
The Viamed Institute of Advanced Surgical Oncology (IVOQA), part of the Viamed Salud group, is at the forefront of fluorescence-guided surgery in the treatment of abdominal cancer, breast cancer, thyroid cancer and peritoneal carcinomatosis.
Thanks to a strong multidisciplinary team, IVOQA combines clinical experience, applied research and continuous education, bringing technological advances directly into the operating room and into all areas of cancer treatment.
Its mission is clear: to improve quality of life, survival and safety for oncology patients through more precise, humane and personalized surgery.
